The CKD group was hallmarked by a slight increase in the frequency of intermediate monocytes (CD14+CD16+), whereas no differences were observed for their classical (CD14+CD16−) and non-classical (CD14lowCD16+) counterparts (Figure 2B). Here, CD14 is linked to chronic kidney disease.